RPRX logo

RPRX
Royalty Pharma plc - Ordinary Shares - Class A

7,275
Mkt Cap
$30.75B
Volume
711.00
52W High
$53.47
52W Low
$32.15
PE Ratio
27.97
RPRX Fundamentals
Price
$53.17
Prev Close
$53.02
Open
$52.77
50D MA
$48.27
Beta
0.35
Avg. Volume
2.98M
EPS (Annual)
$1.78
P/B
3.44
Rev/Employee
$23.78M
$33,378.10
Loading...
Loading...
News
all
press releases
Royalty Pharma Q1 Profit, Revenue Increase; Raises Full-year Portfolio Receipts Outlook
(RTTNews) - Royalty Pharma plc (RPRX) on Thursday reported higher first-quarter earnings, supported mainly by growth in income from financial royalty assets...
Nasdaq News: Markets·8d ago
News Placeholder
More News
News Placeholder
Royalty Pharma Q1 Earnings Call Highlights
Royalty Pharma (NASDAQ:RPRX) reported what executives described as a "strong start" to 2026, driven by double-digit growth in cash receipts, active capital deployment and a series of clinical and regulatory developments across its portfolio, according to management's remarks on the company's first-q...
MarketBeat·9d ago
News Placeholder
RPRX vs. AMGN: Which Stock Is the Better Value Option?
RPRX vs. AMGN: Which Stock Is the Better Value Option?
Zacks·9d ago
News Placeholder
Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript
read more...
Benzinga·9d ago
News Placeholder
Royalty Pharma PLC (RPRX) Hit a 52 Week High, Can the Run Continue?
Royalty Pharma (RPRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·9d ago
News Placeholder
Royalty Pharma (RPRX) Q1 Earnings and Revenues Surpass Estimates
Royalty Pharma (RPRX) delivered earnings and revenue surprises of +6.56% and +3.79%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Royalty Pharma (NASDAQ:RPRX) Hits New 52-Week High - Still a Buy?
Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year High - Here's What Happened...
MarketBeat·10d ago
News Placeholder
Charles River Gears Up for Q1 Earnings: What's in the Cards?
CRL heads into Q1 earnings results with declining EPS estimates, mixed segment trends and Manufacturing Solutions strength offsetting softness in RMS and DSA.
Zacks·11d ago
News Placeholder
PFA Pension Forsikringsaktieselskab Acquires New Holdings in Royalty Pharma PLC $RPRX
PFA Pension Forsikringsaktieselskab purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with...
MarketBeat·12d ago
News Placeholder
Pictet Asset Management Holding SA Sells 62,539 Shares of Royalty Pharma PLC $RPRX
Pictet Asset Management Holding SA cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 16.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 313,510 shares of...
MarketBeat·13d ago
<
1
2
...
>

Latest RPRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.